Turmeric Induced Liver Injury: A Report of Two Cases

Raphael P. Luber, Clarissa Rentsch, Steve Lontos, +6

Case Reports in Hepatology

Severe Adverse EffectsHepatologyViral HepatitisLiver PhysiologyMedicine +13

Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study

Shaji Sebastian, G Walker, Nicholas A. Kennedy, +270

˜The œLancet. Gastroenterology & hepatology

Covid-19 PandemicGastroenterologyInfection ControlInterventional EndoscopyUlcerative Colitis +4

Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study

Zhigang Liu, Kaixing Le, Xin Zhou, +685

˜The œLancet. Gastroenterology & hepatology

Low Mass Blood Peptides Discriminative of Inflammatory Bowel Disease (IBD) Severity: A Quantitative Proteomic Perspective

Valerie C. Wasinger, Yunki Yau, Xizi Duo, +5

Molecular & Cellular Proteomics

A retrospective cohort study: pre‐operative oral enteral nutritional optimisation for Crohnʼs disease in a <scp>UK</scp> tertiary <scp>IBD</scp> centre

Susanna Meade, Kamal Patel, Raphael P. Luber, +17

Alimentary Pharmacology & Therapeutics

Thiopurines vs methotrexate: Comparing tolerability and discontinuation rates in the treatment of inflammatory bowel disease

Abhinav Vasudevan, Nina Parthasarathy, Danny Con, +13

Alimentary Pharmacology & Therapeutics

The effects of COVID‐19 on IBD prescribing and service provision in a UK tertiary centre

Esha Sharma, Susanna Meade, Francesca D’Errico, +17

GastroHep

6-Thioguanine Nucleotide Levels Are Associated With Mucosal Healing in Patients With Crohn’s Disease

Ren Mao, Jing Guo, Raphael P. Luber, +7

Inflammatory Bowel Diseases

An observational study of switching infliximab biosimilar: no adverse impact on inflammatory bowel disease control or drug levels with first or second switch

Raphael P. Luber, R O’Neill, Sukhpreet Singh, +11

Alimentary Pharmacology & Therapeutics

Depression, anxiety, and stress among inflammatory bowel disease patients during COVID‐19: A UK cohort study

Raphael P. Luber, Alexa Duff, Polychronis Pavlidis, +7

JGH Open